|
|
|
16.09.25 - 13:36
|
Mogo Announces Appointment of Joanna Floyd to Board of Directors (Business Wire)
|
|
|
VANCOUVER, British Columbia--(BUSINESS WIRE)--Mogo Inc. (NASDAQ: MOGO; TSX: MOGO), a digital wealth, payments, and Bitcoin company, today announced the appointment of Joanna Floyd to its Board of Directors.
Joanna brings a strong background in global financial services and organizational leadership. She previously held senior talent management roles at Bain Capital and Lehman Brothers after beginning her career in mergers and acquisitions at Deutsche Bank. She is currently Partner and COO of The Work Psychologists, a London-based high-performance leadership consultancy that works with organizations on leadership strategy and organizational effectiveness. Joanna also served on the Board of the Association for Business Psychology and holds an MSc (Distinction) in Business & Occupational Psychology.
“We are pleased to welcome Joanna to Mogo's Board,” said David Feller, Founder & CEO of Mogo. “Her expertise in leadership and organizational effectiveness, combined with her deep understanding of financia...
|
|
|
|
|
14.09.25 - 21:42
|
XFRA: DIVIDEND/INTEREST INFORMATION - 16.09.2025 - US05684B1070 (XETRA)
|
|
|
Das Instrument 618 US05684B1070 BAIN CAP.SPEC.FIN. -,001 EQUITY wird cum Dividende/Zinsen gehandelt am 15.09.2025 und ex Dividende/Zinsen am 16.09.2025
The instrument 618 US05684B1070 BAIN CAP.SPEC.FIN. -,001 EQUITY has its pre-dividend/interest day on 15.09.2025 and its ex-dividend/interest day on 16.09.2025...
|
|
|
|
|
11.09.25 - 18:06
|
Meela Launches Personalized AI Companion to Combat Loneliness Epidemic Among Seniors (Business Wire)
|
|
|
Meela is the first widely accessible AI companion for seniors that does not require additional devices or hardwareNEW YORK--(BUSINESS WIRE)--Meela, a personalized AI companion for seniors, today launched publicly and announced $3.5 million in seed funding led by Bain Capital Ventures (BCV). With these funds, Meela will invest in R&D to expand its product capabilities and clinical efficacy research.
Loneliness is a rapidly growing epidemic in the US that acutely affects the expanding senior population (age 65+), according to the U.S. Surgeon General. One in three seniors report feeling lonely, and 24% are considered socially isolated. Loneliness is correlated with significantly increased risk of heart disease, stroke and early death, with a mortality impact similar to smoking 15 cigarettes a day. At the same time, the U.S. faces a significant shortage of caregivers both in homes and at senior care facilities, which affects the quality of care.
Meela is the first AI companion for seniors that does not requi...
|
|
|
10.09.25 - 22:45
|
Waystar Announces Launch of Secondary Offering of Common Stock (PR Newswire)
|
|
|
LEHI, Utah and LOUISVILLE, Ky., Sept. 10, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY) ("Waystar"), a provider of leading healthcare payments software, today announced that certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment Board (CPP......
|
|
|
|
|
|
|
|
|
|
|
04.09.25 - 14:36
|
HealthEdge and UST HealthProof Merge, Creating Disruptive AI-Powered, Healthcare Payer Technology and Services Leader Under the Ownership of Bain Capital (Business Wire)
|
|
|
Combination creates a leading, next generation claims operating system for payers, with end-to-end AI capabilities for claims, payments, care & utilization management, payment integrity, and member engagement, serving 115+ health plansBOSTON--(BUSINESS WIRE)--HealthEdge and UST HealthProof today announced the successful close of their merger, following Bain Capital's acquisition of UST HealthProof from UST. Financial terms of the transaction were not disclosed.
Headquartered in Boston, the combined company will operate as HealthEdge. With its significant reach into the U.S. healthcare system, touching over 110 million lives, HealthEdge is well-positioned to empower health plans with modern AI-enabled technology and services that lower total costs and improve operational efficiency. The combined company will also be supported by Bain Capital's forty-plus years of experience building and adding value to healthcare companies around the world to drive innovation and improve patient experiences and outcomes....
|
|
|
|
|
01.09.25 - 14:57
|
CapVest erwirbt Mehrheitsanteil an STADA von Bain Capital und Cinven (Business Wire)
|
|
|
CapVest hat eine bindende Vereinbarung über den Kauf eines Mehrheitsanteils an STADA von Bain Capital und Cinven unterzeichnet.
Bain Capital und Cinven behalten jeweils einen Minderheitsanteil an STADA.
STADA CEO Peter Goldschmidt: „CapVest's legt den Schwerpunkt auf eine enge Zusammenarbeit mit dem Management bei der Transformation von Größe und Umfang des Portfolios durch hohe Kapitalzufuhr, eine Kombination von organischem Wachstum und Akquisitionen, operative Exzellenz und Schaffung langfristiger Werte. Dies sind genau die Prinzipien, die STADA erfolgreich gemacht haben."
BAD VILBEL, Deutschland & LONDON--(BUSINESS WIRE)--CapVest Partners LLP („CapVest”), eine führende globale Investmentfirma, hat heute ein endgültiges Abkommen mit Bain Capital und Cinven über den Erwerb der Mehrheitsbeteiligung an der STADA Arzneimittel AG („STADA” oder „das Unternehmen") unterzeichnet. Dieses Unternehmen für Gesundheitspflege und Pharmazie ist spezialisiert auf Consumer Healthcare, Gene...
|
|
|
01.09.25 - 14:39
|
Stada: Paukenschlag – kein Börsengang (Der Aktionaer)
|
|
|
Vorerst wird es aller Voraussicht nach zu keinem Börsen-Comeback des Pharma-Unternehmens Stada kommen. CapVest Partners aus Großbritannien übernimmt die Mehrheit am Grippostad-Hersteller von den Privat-Equity-Gesellschaften Bain Capital und Cinven, die mit einer Minderheit allerdings an Bord bleiben wollen....
|
|
|
|
|
01.09.25 - 08:54
|
CapVest to Acquire Majority Stake in STADA from Bain Capital and Cinven (Business Wire)
|
|
|
CapVest has signed a definitive agreement to acquire the majority stake in STADA from Bain Capital and Cinven
Bain Capital and Cinven will each retain a minority stake in STADA
STADA CEO Peter Goldschmidt: “CapVest's focus on working closely with management in transforming the size and scale of its portfolio companies through significant capital investment, a combination of organic and acquisition led growth, operational excellence, and long-term value creation reflects the same principles that have underpinned STADA's success to date."
BAD VILBEL, Germany & LONDON--(BUSINESS WIRE)--CapVest Partners LLP (“CapVest”), a leading global investment firm, has today signed a definitive agreement with Bain Capital and Cinven to acquire the majority stake in STADA Arzneimittel AG “(STADA” or “the Company”), a leading healthcare and pharmaceuticals company specializing in Consumer Healthcare, Generics and Specialty pharmaceuticals.
Headquartered in Bad Vilbel, Germany, STADA is a leading Europe...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
